A recently published study (1) examined the effects of topical cannabinoid therapy on the inflammatory skin condition atopic dermatitis (AD). Symptoms of the chronic condition can include itching and skin redness, and conventional treatment can result in adverse effects, the study noted. Additionally, previous studies over several years have examined cannabinoids as a safe prevention and management of AD flares. The current study intended to provide more insight on the effect of a particular formulation of cannabinoids within a small study group. The pilot study, “Evaluation of Biophysical Parameters of the Skin of Patients With Atopic Dermatitis After Application of an Ointment Containing 30% Cannabidiol and 5% Cannabigerol,” was published in Clinical, Cosmetic and Investigational Dermatology in March 2025.
Home » Study Tests Cannabinoid-Based Ointment for Managing Atopic Dermatitis Symptoms